COR
Cencora, Inc. · Healthcare · Medical - Distribution
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 163 | 0 | 140.71M | $39.83B | +5 | −4 |
| Q1 2026 | 165 | -4 | 143.75M | $45.15B | +4 | −9 |
| Q4 2025 | 168 | -1 | 154.98M | $52.35B | +1 | −1 |
| Q3 2025 | 24 | +1 | 95.47M | $29.83B | +1 | −1 |
| Q2 2025 | 21 | 0 | 79.61M | $23.87B | — | — |
| Q1 2025 | 18 | +1 | 37.02M | $10.29B | +2 | −1 |
| Q4 2024 | 17 | 0 | 34.14M | $7.67B | — | — |
| Q3 2024 | 16 | 0 | 25.36M | $5.70B | — | — |
| Q2 2024 | 16 | — | 24.85M | $5.60B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 9.15M | — | $2.06B | 0.2% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 9.15M | — | $2.06B | 0.2% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passief) | 4.01M | — | $900.28M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passief) | 4.01M | — | $900.28M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Norges Bank ✦ (passief) | 1.60M | — | $359.83M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 1.08M | — | $244.36M | 0.4% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 1.08M | — | $244.36M | 0.4% | n/c | 1 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 1.06M | — | $238.45M | 0.2% | n/c | 1 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 895.21K | — | $201.69M | 0.5% | n/c | 1 | SEC ↗ |
| 19 | Millennium Management ✦ | 653.01K | — | $147.12M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 371.51K | — | $83.70M | 0.1% | n/c | 1 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 371.51K | — | $83.70M | 0.1% | n/c | 1 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 355.50K | — | $80.09M | 0.1% | n/c | 1 | SEC ↗ |
| 23 | Adage Capital Partners ✦ | 292.67K | — | $65.94M | 0.1% | n/c | 1 | SEC ↗ |
| 24 | Bridgewater Associates ✦ | 255.47K | — | $57.56M | 0.3% | n/c | 1 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 235.34K | — | $53.02M | 0.1% | n/c | 1 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 26.52K | — | $5.97M | 0.1% | n/c | 1 | SEC ↗ |
| 27 | Marshall Wace ✦ | 6.83K | — | $1.54M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Fisher Asset Management ✦ | 1.08K | — | $244,562 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 3 houders, 139 aandelen, $43,570 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 11.30K aand · $3.66M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie